Prostate Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Prostate Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Results: A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating talazoparib in combination with temozolomide in prostate cancer has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-08-14Clinical Trial Update: Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer [Phase 3]
Phase 3 clinical trial update for Copper-64 PSMA I&T PET imaging in men with newly diagnosed prostate cancer; study status is active not rec…
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Results: Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer [Phase 2]
Phase 2 clinical trial results of flibanserin in men undergoing androgen suppression for prostate cancer have been completed.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating external beam radiotherapy and high-dose-rate brachytherapy for unfavorable-intermediate, high, and very high-risk …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer [Phase 3]
A Phase 3 study evaluating Copper-64 PSMA I&T PET imaging for men with suspected recurrence of prostate cancer has completed, sponsored by C…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 trial of Erdafitinib in castration-resistant prostate cancer was terminated; the document provides the status update without repor…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS [Phase 1, Phase 2]
A clinical trial update for AS1986NS describing a single-arm, blinded fluorescent PSMA histopathology study in prostate cancer across Phase …
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery [Phase 2, Phase 3]
Clinical trial update describing Phase 2/3 evaluation of antiandrogen therapy with radiation, with or without the chemotherapy drug docetaxe…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study [NA]
Pilot trial evaluating a diet and physical activity intervention to prevent ADT-induced metabolic changes in men with prostate cancer; the s…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC [Phase 3]
A Phase 3 study evaluating cabozantinib in combination with atezolizumab versus a second hormonal therapy in metastatic castration-resistant…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy
A clinical trial evaluating adding MR fusion to standard ultrasound-guided prostate biopsy is suspended, indicating halted study activity.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer [NA]
A completed clinical trial is evaluating neoadjuvant Diffusing Alpha Emitters Radiation Therapy (DaRT) brachytherapy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Fluorescent Imaging of Nerves With Illuminare-1 During Surgery [Phase 1]
Phase 1 clinical trial update evaluating Illuminare-1 for fluorescent nerve imaging during prostate cancer surgery.
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: PROState Pathway Embedded Comparative Trial
The PROState Pathway Embedded Comparative Trial conducted by Imperial College London has completed and posted results on 2025-06-18.
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer [Phase 2]
A Phase 2 trial update reports completing the study investigating combining EPI-7386 with enzalutamide and androgen deprivation therapy in m…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating whether a soy bread diet improves immune function in men with prostate cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer [NA]
A completed clinical trial evaluating a novel surgery for prostate cancer has posted results.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer [NA]
The trial, a Phase I-II dose-escalation study of stereotactic body radiation therapy for localized prostate cancer, has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma [Phase 2]
Phase 2 trial evaluating olaparib in castration-resistant prostate cancer was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients [Phase 1]
A Phase 1 trial investigating extending relugolix dosing intervals by co-administering itraconazole or ritonavir in prostate cancer patients…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer [Phase 2]
Phase 2 trial update evaluating Gallium-68 DOTA-NeoBOMB1 and Gallium-68 PSMA-R2 PET/MRI for diagnosing recurrent prostate cancer with PSA pr…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain [Phase 4]
Phase 4 trial evaluating self-administered nitrous oxide to reduce anxiety and pain during transrectal prostate biopsy; study completed with…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 [Phase 2]
Phase 2 trial update for hypofractionated focal lesion ablative microboost in prostate cancer (prostate adenocarcinoma).
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer [Phase 2]
Phase 2 trial investigating erdafitinib combined with abiraterone acetate or enzalutamide in double negative prostate cancer; study terminat…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating androgen deprivation combined with docetaxel and enzalutamide for metastatic prostate cancer; resul…